PERSPECTA

News from every angle

Back to headlines

LifeMD Targets $250M+ Annualized Revenue by Q4 2026

LifeMD has outlined a target of achieving over $250 million in annualized revenue run rate by the fourth quarter of 2026, driven by record demand for GLP-1 drugs and expanded partnerships.

9 Mar, 22:39 — 9 Mar, 22:39
PostShare

Sources

Showing 1 of 1 sources